STATE OF MICHIGAN
COURT OF APPEALS
PEOPLE OF THE STATE OF MICHIGAN, UNPUBLISHED
October 2, 2018
Plaintiff-Appellee,
v No. 342998
Oakland Circuit Court
DAVID CLARENCE BRYAN, LC No. 2017-262223-FH
Defendant-Appellant.
Before: M. J. KELLY, P.J., and MARKEY and FORT HOOD, JJ.
PER CURIAM.
This case is before this Court on remand from the Michigan Supreme Court for
consideration as on leave granted. People v Bryan, ___ Mich ___; 911 NW2d 731 (2018).
Defendant challenges the trial court’s order denying his motion to (1) dismiss the marijuana-
related charges against him and (2) allow him to present an affirmative defense to his marijuana-
related offenses at trial. We affirm.
I. BACKGROUND
Defendant was charged with one count of possession with intent to deliver marijuana,1
MCL 333.7401(2)(d)(iii), one count of possession with intent to deliver 5 kilograms or more, but
less than 45 kilograms, of marijuana, MCL 333.7401(2)(d)(ii), two counts of possession of a
firearm during the commission of a felony (felony-firearm), MCL 750.227b, and one count of
careless discharge of a firearm resulting in property damage of $50 or less, MCL 752.862. In the
trial court, defendant filed a motion seeking dismissal of the marijuana-related offenses under
MCL 333.26428 (the “§8 affirmative defense”), part of the Michigan Medical Marihuana Act
(MMMA), MCL 333.26421 et seq. Alternatively, defendant requested that he be able to present
the § 8 affirmative defense at trial. Following an evidentiary hearing, the trial court denied
defendant’s motion. On March 26, 2018, defendant filed an interlocutory application for leave to
appeal in this Court. On May 14, 2018, defendant filed a motion seeking to stay his trial date
pending appeal and a motion for immediate consideration of his motion for stay. On May 15,
1
We will use the more common spelling, “marijuana,” except when quoting the Michigan
Medical Marihuana Act.
-1-
2018, this Court granted defendant’s motion for immediate consideration and denied both
defendant’s application for leave to appeal and his motion for stay pending appeal. People v
Bryan, unpublished order of the Court of Appeals, entered May 15, 2018 (Docket No. 342998).
On May 18, 2018, defendant filed an application for leave to appeal to the Michigan
Supreme Court, as well as a motion for stay pending appeal and a motion for immediate
consideration of his motion for stay. Defendant’s arguments in his application for leave to
appeal to the Michigan Supreme Court mirrored those in his application for leave to appeal to
this Court. On May 30, 2018, the Michigan Supreme Court granted defendant’s motion for
immediate consideration, remanded the case to this Court “for consideration as on leave
granted,” and granted defendant’s motion for stay. People v Bryan, ___ Mich ___; 911 NW2d
731 (2018).
II. ANALYSIS
Defendant argues that the trial court erred in denying him the opportunity to assert the §8
affirmative defense at trial where he presented prima facie evidence of each element of §8. We
disagree.
A. STANDARD OF REVIEW
“[The Court of Appeals] review[s] for an abuse of discretion a circuit court’s ruling on a
motion to dismiss but review[s] de novo the circuit court’s rulings on underlying questions
regarding the interpretation of the MMMA, which the people enacted by initiative in November
2008.” People v Bylsma, 493 Mich 17, 26; 825 NW2d 543 (2012) (citations omitted). “An
abuse of discretion occurs when the trial court’s decision is outside the range of principled
outcomes.” People v Daniels, 311 Mich App 257, 265; 874 NW2d 732 (2015). This Court
reviews “the evidence de novo to determine whether the trial court properly granted or denied
the defendant’s motion to dismiss under § 8.” People v Anderson (On Remand), 298 Mich App
10, 16; 825 NW2d 641 (2012).
In People v Kolanek, 491 Mich 382, 394; 817 NW2d 528 (2012), the Michigan Supreme
Court stated:
The MMMA does not create a general right for individuals to use and possess
marijuana in Michigan. Possession, manufacture, and delivery of marijuana
remain punishable offenses under Michigan law. Rather, the MMMA’s
protections are limited to individuals suffering from serious or debilitating
medical conditions or symptoms, to the extent that the individuals’ marijuana use
is carried out in accordance with the provisions of [the MMMA]. [Alteration in
original; footnote omitted).]
“A defendant seeking to assert the MMMA’s statutory affirmative defense must present
prima facie evidence for each element of § 8(a).” People v Hartwick, 498 Mich 192, 228; 870
NW2d 37 (2015). When considering a motion to dismiss under § 8(a) of the MMMA or a
request to present the affirmative defense at trial, a “trial court may not weigh the evidence,
assess credibility, or resolve factual disputes at the hearing.” Anderson (On Remand), 298 Mich
App at 16 (citation and quotation marks omitted). “Rather, the trial court must determine—as a
-2-
matter of law—if the defendant established his or her right to have the charges dismissed under §
8, or if there are material factual disputes that must be resolved by a jury.” Id. (citation and
quotation marks omitted).
B. THE SECTION 8 AFFIRMATIVE DEFENSE
Section 8 of the MMMA, MCL 333.26428, provides, in pertinent part:
(a) Except as provided in section 7(b), a patient and a patient’s primary caregiver,
if any, may assert the medical purpose for using marihuana as a defense to any
prosecution involving marihuana, and this defense shall be presumed valid where
the evidence shows that:
(1) A physician has stated that, in the physician’s professional opinion, after
having completed a full assessment of the patient’s medical history and current
medical condition made in the course of a bona fide physician-patient
relationship, the patient is likely to receive therapeutic or palliative benefit from
the medical use of marihuana to treat or alleviate the patient’s serious or
debilitating medical condition or symptoms of the patient’s serious or debilitating
medical condition;
(2) The patient and the patient’s primary caregiver, if any, were collectively in
possession of a quantity of marihuana that was not more than was reasonably
necessary to ensure the uninterrupted availability of marihuana for the purpose of
treating or alleviating the patient’s serious or debilitating medical condition or
symptoms of the patient’s serious or debilitating medical condition; and
(3) The patient and the patient’s primary caregiver, if any, were engaged in the
acquisition, possession, cultivation, manufacture, use, delivery, transfer, or
transportation of marihuana or paraphernalia relating to the use of marihuana to
treat or alleviate the patient’s serious or debilitating medical condition or
symptoms of the patient’s serious or debilitating medical condition.
With regard to the § 8 affirmative defense, the Michigan Supreme Court has stated:
In Kolanek, we determined that if a defendant establishes these elements and no
question of fact exists regarding these elements, then the defendant is entitled to
dismissal of the criminal charges. We also clarified that if questions of fact exist,
then “dismissal of the charges is not appropriate and the defense must be
submitted to the jury.” Additionally, if a defendant has not presented prima facie
evidence of each element of § 8 by “present[ing] evidence from which a
reasonable jury could conclude that the defendant satisfied the elements of the § 8
affirmative defense, . . . then the circuit court must deny the motion to dismiss the
charges,” and “the defendant is not permitted to present the § 8 defense to the
jury.” [Hartwick, 498 Mich at 227, citing Kolanek, 491 Mich at 416.]
-3-
The § 8 affirmative defense may not be presented to the jury when that defense fails as a
matter of law because to do so “would unnecessarily burden the jury and the circuit court with
irrelevant testimony.” Kolanek, 491 Mich at 413.
C. THE ELEMENTS OF THE SECTION 8 AFFIRMATIVE DEFENSE
As the trial court recognized during its bench ruling, the key issue in this case is whether
defendant presented prima facie evidence to establish that he possessed, cultivated, manufactured
and used marijuana “to treat or alleviate [his] serious or debilitating medical condition or
symptoms of [his] serious or debilitating medical condition.” MCL 333.26428(a)(3).
Accordingly, the trial court focused on subsection (a)(3) in its bench ruling. However, to the
extent that defendant asserts that he presented prima facie evidence to satisfy the statutory
requirements of MCL 333.26428(a)(1) and (2), we will briefly review the record evidence as it
relates to these elements of the § 8 affirmative defense.
As the Michigan Supreme Court observed in Hartwick, 498 Mich at 228, “[s]ection
8(a)(1) requires a physician to determine the patient’s suitability for the medical use of
marijuana.” The prosecution asserts that defendant and Dr. Scott Graves did not have a “bona
fide physician-patient relationship” as contemplated by § 8(a)(1) and therefore defendant cannot
meet the requirements of § 8(a)(1).
MCL 333.26423(a) defines a bona-fide physician-patient relationship in the following
manner:
(a) “Bona fide physician-patient relationship” means a treatment or counseling
relationship between a physician and patient in which all of the following are
present:
(1) The physician has reviewed the patient’s relevant medical records and
completed a full assessment of the patient’s medical history and current medical
condition, including a relevant, in-person, medical evaluation of the patient.
(2) The physician has created and maintained records of the patient’s condition in
accord with medically accepted standards.
(3) The physician has a reasonable expectation that he or she will provide follow-
up care to the patient to monitor the efficacy of the use of medical marihuana as a
treatment of the patient’s debilitating medical condition.
(4) If the patient has given permission, the physician has notified the patient’s
primary care physician of the patient’s debilitating medical condition and
certification for the use of medical marihuana to treat that condition.
“As part of the process for obtaining a registry identification card, an applicant must submit,
among other materials, a ‘written certification.’” Hartwick, 498 Mich at 229, quoting MCL
-4-
333.26426(a)(1). “[T]he actual text of the physician’s statement submitted as part of the
registration process [could] suffice” to establish that there was a bona fide physician-patient
relationship, or satisfy each element of the physician-patient relationship. Id. at 231 n 77.2 A
defendant may also present other evidence at an evidentiary hearing to meet the requirements of
§ 8(a)(1). Id.
During the evidentiary hearing, defendant testified that he held a registry identification
card for the use of marijuana for a medical purpose “[b]ecause of ongoing pain” that was the
result of breaking his back in a motor vehicle accident on January 13, 2014. 3 Defendant also
testified regarding his professional relationship with Dr. Graves, which began in 2012, and
submitted Dr. Graves’s written certifications for defendant’s registry identification card. Dr.
Graves is the only doctor defendant has seen regarding his registry identification card.
Defendant indicated that he submitted several documents that Dr. Graves had completed to the
Michigan Department of Licensing and Regulatory Affairs (LARA). For example, one of the
documents, dated August 20, 2015, contained an attestation from Dr. Graves that he had
completed a full assessment of defendant’s medical history and current medical condition,
including an in-person medical evaluation. The attestation also indicated that Dr. Graves
believed defendant would benefit from the medical use of marijuana to treat his debilitating
medical condition.
Defendant also described the nature of his visits with Dr. Graves during his testimony at
the evidentiary hearing. For example, on August 20, 2015, defendant saw Dr. Graves to renew
his registry identification card. Defendant indicated that normal medical procedures took place
during his visit: Dr. Graves took his blood pressure, temperature, vital signs, listened to his heart,
and looked in his nose and throat. Defendant also had to fill out forms, including one that
discussed defendant’s various health issues. While at Dr. Graves’s office, defendant spoke with
2
MCL 333.26423(q) provides, in pertinent part, as follows:
(q) “Written certification” means a document signed by a physician, stating all of
the following:
(1) The patient’s debilitating medical condition.
(2) The physician has completed a full assessment of the patient’s medical history
and current medical condition, including a relevant, in-person, medical
evaluation.
(3) In the physician’s professional opinion, the patient is likely to receive
therapeutic or palliative benefit from the medical use of marihuana to treat or
alleviate the patient’s debilitating medical condition or symptoms associated with
the debilitating medical condition.
3
On appeal, the prosecution does not contest that defendant’s pain in his back and legs resulted
in him suffering from a serious or debilitating medical condition. MCL 333.26428(a)(1).
-5-
Dr. Graves about his medical condition, the medical issues he had as a result of his 2014 motor
vehicle accident, and his interactions with Dr. Jawad Shah, a neurosurgeon who defendant began
treating with after his January 2014 motor vehicle accident. Defendant gave Dr. Graves
permission to speak with and send his medical records to Dr. Shah. While defendant explained
at one point during the evidentiary hearing that he “was not there for treatment” when he
consulted with Dr. Graves, but to obtain his registry identification card, this evidence presents a
factual dispute with regard to whether defendant and Dr. Graves had a “bona fide physician-
patient relationship,” MCL 333.26428(a)(1). It is the role of the jury to weigh this evidence at
trial. Hartwick, 498 Mich at 227. Therefore, considered in its totality, the record demonstrates
that defendant presented prima facie evidence to establish that he had an “actual and ongoing
physician-patient relationship at the time” Dr. Graves submitted written certifications in support
of defendant’s registry identification card for the medical use of marijuana, Hartwick, 498 Mich
at 231, and we are therefore satisfied that defendant presented prima facie evidence to meet the
statutory requirement of § (8)(a)(1).
Defendant also argues that he presented prima facie evidence to meet the requirement of
MCL 333.26428(a)(2), which specifies that the amount of marijuana that defendant possessed
may not be more than “reasonably necessary to ensure the uninterrupted availability of”
marijuana to treat defendant’s serious or debilitating medical condition or its symptoms. MCL
333.26428(a)(2). In Hartwick, the Michigan Supreme Court recognized:
A patient seeking to assert a § 8 affirmative defense may have to testify
about whether a specific amount of marijuana alleviated the debilitating medical
condition and if not, what adjustments were made to the consumption rate and the
amount of marijuana consumed to determine an appropriate quantity. Once the
patient establishes the amount of usable marijuana needed to treat the patient’s
debilitating medical condition, determining whether the patient possessed “a
quantity of marihuana that was not more than was reasonably necessary to ensure
[its] uninterrupted availability” also depends on how the patient obtains marijuana
and the reliability of this source. This would necessitate some examination of the
patient/caregiver relationship. [Hartwick, 498 Mich at 234.]
“[A] § 8 defense may be available without regard to whether the marijuana possessed was usable
marijuana and without regard to the quantity possessed.” People v Carruthers, 301 Mich App
590, 616; 837 NW2d 16 (2013). Instead, with regard to this element, a patient seeking to assert
the § 8 affirmative defense must present evidence to establish that the amount of marijuana in his
or her possession was “not more than was reasonably necessary for the statutorily recognized
purposes[.]” Id. at 617. As noted above, the trial court correctly determined that whether
defendant presented evidence to satisfy § 8(a)(3) was the pivotal issue in this case. “Section
8(a)(3) requires both the patient’s and the primary caregiver’s use of marijuana be for a medical
purpose,” regardless of registration status. Hartwick, 498 Mich at 237. Therefore, defendant, as
a patient as contemplated by § 8(a)(3), must “present prima facie evidence regarding [his] use of
marijuana for a medical purpose . . . [.]” Id. For ease of analysis, we will review together the
questions whether defendant presented prima facie evidence to support § 8(a)(2) and (3).
When Oakland County Sheriff’s Deputies Richard Hubble and Michael Knopp entered
defendant’s house on November 29, 2016, defendant was growing marijuana in his basement
-6-
that he claimed was for medical purposes. Defendant testified during the evidentiary hearing
that he suffered from “extreme pain” arising from breaking his back in the January 13, 2014
automobile accident. Defendant recounted that at the time the police searched his home on
November 29, 2016, he had 13 marijuana plants and 12 or 13 “clones” that “were in the process
of being rooted.” When asked how much loose marijuana he had, defendant stated, “I couldn’t
even make an honest guess.” Around November 29, 2016, defendant was smoking, “[o]n an
average day, between seven and probably 15 grams” of marijuana. When asked whether he felt
the 7 to 15 grams of marijuana he used on a daily basis was his “proper dosage,” defendant
stated, “In a roundabout way, yes, sir.” Defendant indicated that this amount helped him
medically.
With respect to the marijuana found in his home, defendant indicated that there were
“three plants ready for harvest” that were hanging in the basement, as well as “other plants that
were still hanging that [he] hadn’t processed that were contaminated.” The growing process took
approximately six months. Defendant testified that following the drying process of the
marijuana, “most plants would yield between two and three ounces of what [he] considered
usable marihuana for [his] purposes, and the rest of it would be discarded.” Defendant did not
believe that the amount of marijuana that was found in his home “would have lasted [him] until
[his] next crop was ready[,]” and conceded that the supply in his home was in fact less than what
he required to meet his medical needs. However, the record also reflects that the police
suspected defendant of selling marijuana after viewing text messages on his cellular telephone
when they entered his home on November 29, 2016, and defendant himself testified that he
traded marijuana with his neighbor to have particular strains of marijuana available. Under such
circumstances, factual disputes do not exist concerning whether the quantity of marijuana that
defendant possessed was “reasonably necessary to ensure the uninterrupted availability of
[marijuana] for the purpose of” treating his serious or debilitating medical condition. MCL
333.26428(a)(2).
Moreover, defendant’s testimony at the evidentiary hearing did not establish, by a
preponderance of the evidence, that his use of marijuana was to “treat or alleviate [defendant’s]
serious or debilitating medical condition” or its symptoms. Hartwick, 498 Mich at 228 n 69;
MCL 333.26428(a)(3). In Hartwick, the Michigan Supreme Court stated:
Although there is a purposeful distinction made between the amount of
marijuana permitted under § 4 and the “reasonably necessary” restraint on
quantity found in § 8(a)(2), § 8(a)(3) requires a patient and primary caregiver to
show that any marijuana use complied with a very similar “medical use”
requirement found in § 4, and defined in § 3([h]). [Hartwick, 498 Mich at 236.]
As set forth in MCL 333.26423(h),
“Medical use of marihuana” means the acquisition, possession, cultivation,
manufacture, extraction, use, internal possession, delivery, transfer, or
transportation of marihuana, marihuana-infused products, or paraphernalia
relating to the administration of marihuana to treat or alleviate a registered
qualifying patient’s debilitating medical condition or symptoms associated with
the debilitating medical condition.
-7-
It cannot go unnoticed that, during his testimony at the evidentiary hearing, defendant
stated that he used marijuana as a replacement for tobacco as he was quitting smoking tobacco.
Similarly, as noted previously in this opinion, the record evidence also demonstrated that when
the police entered defendant’s home on November 29, 2016 and examined text messages found
on his cellular telephone, they found messages consistent with defendant selling marijuana to a
third person. Defendant also stated at one point during his testimony at the evidentiary hearing
that he would share his marijuana with a neighbor or seek marijuana from that same neighbor if
defendant’s own supply was exhausted. Therefore, on this record, where factual disputes did not
exist regarding whether defendant’s possession and use of marijuana was “to treat or alleviate
[his] serious or debilitating medical condition” or its symptoms, we are not persuaded that the
trial court’s decision to deny defendant’s motion to present the § 8 affirmative defense at trial fell
outside the range of reasonable and principled outcomes and amounted to an abuse of discretion.
Bylsma, 493 Mich at 26; Daniels, 311 Mich App at 265.
Affirmed.
/s/ Michael J. Kelly
/s/ Jane E. Markey
/s/ Karen M. Fort Hood
-8-